Filter
3967
Filtered Results: 3967
Text search:
drug-related
problems
Featured
Recommendations
347
New Publications
1105
Language
Document type
No document type
2588
Studies & Reports
567
Guidelines
434
Manuals
162
Strategic & Response Plan
106
Training Material
55
Fact sheets
28
Situation Updates
13
Resource Platforms
6
Infographics
4
Brochures
2
App
1
Online Courses
1
Countries / Regions
India
257
Global
125
Kenya
111
Ethiopia
108
South Africa
106
Western and Central Europe
97
Tanzania
88
Uganda
87
Nigeria
82
Nepal
77
Sierra Leone
75
Liberia
72
Malawi
62
Zambia
61
Bangladesh
60
Myanmar / Burma
58
Ghana
51
Latin America and the Carribbean
48
Rwanda
47
Philippines
45
Africa
44
Eastern Europe
42
Namibia
42
Ukraine
38
Zimbabwe
31
South–East Asia Region
29
Cambodia
27
Asia
26
Lesotho
24
Botswana
22
Russia
19
Indonesia
18
Syria
17
Mozambique
15
Eswatini/ Swaziland
15
Congo, Democratic Republic of
13
Cameroon
10
Burkina Faso
10
Tajikistan
9
Colombia
9
Thailand
9
Senegal
9
Haiti
9
Germany
9
Albania
8
Guinea
8
East and Southern Africa
8
Brazil
8
South Sudan
8
Afghanistan
7
USA
7
Eastern Europe and Central Asia
7
Georgia
7
Venezuela
6
Vietnam
6
Sudan
6
Pakistan
6
North Macedonia
5
China
5
Laos
5
Middle East and North Africa
5
Benin
4
West and Central Africa
4
Western Pacific Region
4
Jamaica
4
Argentina
4
Moldova
4
Iraq
4
Mexico
3
Fiji
3
Kyrgyzstan
3
Armenia
3
Jordan
3
North America
3
United Kingdom
3
Lebanon
3
Papua New Guinea
3
Sri Lanka
3
Bhutan
3
Switzerland
2
Timor Leste/ East Timor
2
Serbia
2
Kazakhstan
2
Chile
2
Iran
2
Canada
2
Estonia
2
Peru
2
Hungary
2
Paraguay
2
Southern Africa
2
Yemen
2
Palestine
2
Central African Republic
2
Poland
2
Libya
2
Somalia
2
El Salvador
1
Turkey
1
Gambia
1
Singapore
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Norway
1
Portugal
1
Belarus
1
Bolivia
1
Egypt
1
Romania
1
Mali
1
Authors & Publishers
Publication Years
Category
Countries
1568
Clinical Guidelines
328
Public Health
220
Women & Child Health
166
Key Resources
120
Capacity Building
78
Pharmacy & Technologies
40
Annual Report MEDBOX
1
Toolboxes
Mental Health
513
HIV
394
TB
328
AMR
191
NTDs
159
Pharmacy
114
COVID-19
92
Caregiver
85
NCDs
78
Rapid Response
59
Disability
55
Refugee
54
Planetary Health
53
Conflict
50
Ebola & Marburg
48
Global Health Education
44
Health Financing Toolbox
27
Natural Hazards
18
Polio
17
Social Ethics
14
Specific Hazards
13
Cholera
11
Zika
10
Malaria
5
In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles...
This FY 2018 Malaria Operational Plan (MOP) presents a detailed implementation plan for Ethiopia, based on the strategies of PMI and the National Malaria Control Program (NMCP). It was developed in consultation with the Federal Ministry of Health (FMOH), NMCP, Ethiopian Public Health Institute (EP...
Care for persons with noncommunicable diseases (NCDs), such as cardiovascular disease, diabetes, cancer, and chronic obstructive pulmonary disease, is a major health priority for most countries worldwide, particularly for low-middle income countries where the problem seems to be worsening. Globally,...
The DHS report itself explains the purpose was, “to obtain and provide information on basic indicators of social progress including fertility, childhood mortality, reproductive and child health, nutritional status of children, and awareness of HIV/AIDS and other health-related issues” in PNG. Th...
Cognizant of the need for standardization of the response for COVID-19, the Federal Ministry of Health prepared this national guideline in an effort to contain the epidemic before it overwhelms the health care facilities. This national guideline is expected to guide policy makers and h...
The threat posed by antimicrobial resistance (AMR) to public health as well as global health security has been reiterated in umerous World Health Assembly (WHA) resolutions. AMR is also prioritized under the Global Health Security Agenda (GHSA), and India is one of the contributing countries. The Mi...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to ...
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
The 2018 edition of the guidelines includes the re...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
The goal of asthma treatment is to obtain clinical control and reduce future risks to the patient. To reach this goal in children with asthma, ongoing monitoring is essential. While all components of asthma, such as symptoms, lung function, bronchial hyperresponsiveness and inflammation, may exist i...
The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and antimicrobial resistance (AMR) in bacteria from humans and food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance networks for 2013–2015. AMC in both sectors, exp...
Infectious diseases are constantly in transition. New diseases develop, known dis-eases become widespread or reemerge, and occasionally a disease is eradicated.Infectious diseases such as HIV, tuberculosis, and cholera are significant causes ofillness and death in many parts of the world. Health car...
Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region
Since 2019, we have been implementing Phase 2 of the regional Transformation Agenda, which informs and aligns with the global WHO Transformation, to ensure WHO is accountable, driven by re- sults and provid...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
